Glatiramer Acetate Injection
Generic Name: glatiramer acetate injection
Brand Names:
Glatiramer Acetate
11 DESCRIPTION Glatiramer acetate, the active ingredient of Glatiramer Acetate Injection, consists of the acetate salts of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine with an average molar fraction of 0.141, 0.427, 0.095, and 0.338, respectively. The average molecular weight of glatiramer acetate is 5,000 – 9,000 daltons. Glatiramer acetate is identified by specific antibodies.
Overview
11 DESCRIPTION Glatiramer acetate, the active ingredient of Glatiramer Acetate Injection, consists of the acetate salts of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine with an average molar fraction of 0.141, 0.427, 0.095, and 0.338, respectively. The average molecular weight of glatiramer acetate is 5,000 – 9,000 daltons. Glatiramer acetate is identified by specific antibodies.
Uses
1 INDICATIONS AND USAGE Glatiramer Acetate Injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatiramer Acetate Injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 ).
Dosage
2 DOSAGE AND ADMINISTRATION For subcutaneous injection only; doses are not interchangeable ( 2.1 ) Glatiramer Acetate Injection 20 mg/mL per day ( 2.1 ) Glatiramer Acetate Injection 40 mg/mL three times per week ( 2.1 ) Before use, allow the solution to warm to room temperature ( 2.2 ) 2.1 Recommended Dose Glatiramer Acetate Injection is for subcutaneous use only [see Dosage and Administration ( 2.2 )] . Do not administer intravenously. The dosing schedule depends on the product strength that is selected.
Side Effects
6 ADVERSE REACTIONS The following serious adverse reactions are described elsewhere in the labeling: Anaphylactic Reactions [see Warnings and Precautions ( 5.1 )] Immediate Post-Injection Reaction [see Warnings and Precautions ( 5.2 )] Chest Pain [see Warnings and Precautions ( 5.3 )] Lipoatrophy and Skin Necrosis [see Warnings and Precautions ( 5.4 )] Potential Effects on Immune Response [see Warnings and Precautions ( 5.5 )] Hepatic Injury [see Warnings and Precautions ( 5.6 )] In controlled studies of Glatiramer Acetate Injection 20 mg/mL, most common adverse reactions (≥10% and ≥1.5 times higher than placebo) were: injection site reactions, vasodilatation, rash, dyspnea, and chest pain ( 6.1 ) In a controlled study of Glatiramer Acetate Injection 40 mg/mL, most common adverse reactions...
Warnings
WARNING: ANAPHYLACTIC REACTIONS WARNING: ANAPHYLACTIC REACTIONS Cases of life-threatening and fatal anaphylaxis have been reported with Glatiramer Acetate Injection. Anaphylaxis can occur at any time following initiation of therapy, from as early as after the first dose, up to years following initiation of therapy. 5 WARNINGS AND PRECAUTIONS Immediate Post-Injection Reaction (flushing, chest pain, palpitations, tachycardia, anxiety, dyspnea, throat constriction, and/or urticaria), may occur within seconds to minutes after injection and are generally transient and self-limiting ( 5.2 ) Chest pain, usually transient ( 5.3 ) Lipoatrophy and skin necrosis may occur. 4 CONTRAINDICATIONS Glatiramer Acetate Injection is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol. Reactions have included anaphylaxis [see Warnings and Precautions ( 5.1 )] . Known hypersensitivity to glatiramer acetate or mannitol ( 4 )
Pregnancy
8.1 Pregnancy Risk Summary Available data from pharmacovigilance and published observational studies over decades of use with glatiramer acetate during pregnancy have not identified a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes ( see Data ). Administration of glatiramer acetate by subcutaneous injection to pregnant rats and rabbits resulted in no adverse effects on embryofetal or offspring development ( see Data) . The background risk of major birth defects and miscarriage for the indicated population is unknown.
Storage
16 HOW SUPPLIED/STORAGE AND HANDLING Glatiramer Acetate Injection is a clear, colorless to slightly yellow, sterile, nonpyrogenic solution supplied as: 20 mg per mL in a single-dose, prefilled syringe with a white plunger, in individual blister packages supplied in 30-count cartons (NDC 0832-6084-30).
Frequently Asked Questions
What is Glatiramer Acetate Injection used for?▼
1 INDICATIONS AND USAGE Glatiramer Acetate Injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatiramer Acetate Injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 ).
What are the side effects of Glatiramer Acetate Injection?▼
6 ADVERSE REACTIONS The following serious adverse reactions are described elsewhere in the labeling: Anaphylactic Reactions [see Warnings and Precautions ( 5.1 )] Immediate Post-Injection Reaction [see Warnings and Precautions ( 5.2 )] Chest Pain [see Warnings and Precautions ( 5.3 )] Lipoatrophy and Skin Necrosis [see Warnings and Precautions ( 5.4 )] Potential Effects on Immune Response [see Warnings and Precautions ( 5.5 )] Hepatic Injury [see Warnings and Precautions ( 5.6 )] In controlled studies of Glatiramer Acetate Injection 20 mg/mL, most common adverse reactions (≥10% and ≥1.5 times higher than placebo) were: injection site reactions, vasodilatation, rash, dyspnea, and chest pain ( 6.1 ) In a controlled study of Glatiramer Acetate Injection 40 mg/mL, most common adverse reactions...
Can I take Glatiramer Acetate Injection during pregnancy?▼
8.1 Pregnancy Risk Summary Available data from pharmacovigilance and published observational studies over decades of use with glatiramer acetate during pregnancy have not identified a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes ( see Data ). Administration of glatiramer acetate by subcutaneous injection to pregnant rats and rabbits resulted in no adverse effects on embryofetal or offspring development ( see Data) . The background risk of major birth defects and miscarriage for the indicated population is unknown.
What are the important warnings for Glatiramer Acetate Injection?▼
WARNING: ANAPHYLACTIC REACTIONS WARNING: ANAPHYLACTIC REACTIONS Cases of life-threatening and fatal anaphylaxis have been reported with Glatiramer Acetate Injection. Anaphylaxis can occur at any time following initiation of therapy, from as early as after the first dose, up to years following initiation of therapy. 5 WARNINGS AND PRECAUTIONS Immediate Post-Injection Reaction (flushing, chest pain, palpitations, tachycardia, anxiety, dyspnea, throat constriction, and/or urticaria), may occur within seconds to minutes after injection and are generally transient and self-limiting ( 5.2 ) Chest pain, usually transient ( 5.3 ) Lipoatrophy and skin necrosis may occur. 4 CONTRAINDICATIONS Glatiramer Acetate Injection is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol. Reactions have included anaphylaxis [see Warnings and Precautions ( 5.1 )] . Known hypersensitivity to glatiramer acetate or mannitol ( 4 )
Related Medications
Calamine, Zinc Oxide
calamine, zinc oxide
Purpose Skin protectant
Cimicifugad6, Droserad6, Formica Rufad6, Fuligod6, Inula Held6, Kali Murd6, Lapis Albusd6, Silicead6
cimicifugad6, droserad6, formica rufad6, fuligod6, inula held6, kali murd6, lapis albusd6, silicead6
Uses Temporarily relieves occasional heavy bleeding or painful periods, bleeding between periods, fullness and pressure in the pelvic area, frequent urination, discomfort during coitus, and lower back discomfort. It temporarily supports your body when dealing with uterine and reproductive issues (e.g., difficulty conceiving).* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE, NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any
Fagopyrum Esculentum, Magnesia Muriatica, Citrus Bioflavonoids, Heart (suis), Thyroidinum (suis), Arsenicum Iodatum, Aurum Muriaticum, Baryta Muriatica, Calcarea Iodata, Cholesterinum, Conium Maculatum, Kali Iodatum, Plumbum Metallicum, Arnica Montana, Phosphorus
fagopyrum esculentum, magnesia muriatica, citrus bioflavonoids, heart (suis), thyroidinum (suis), arsenicum iodatum, aurum muriaticum, baryta muriatica, calcarea iodata, cholesterinum, conium maculatum, kali iodatum, plumbum metallicum, arnica montana, phosphorus
INDICATIONS: For temporary relief of cold clammy feet, numbness of limbs, painful calves upon walking, muscular weakness of the lower extremities.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.